Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Vratsa – page 5

55 clinical trials in Vratsa, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Vratsa at a glance
55
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

55 trials in Vratsa

Open in trial search

Asthma

Not recruiting

Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Asthma

Not recruiting

Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Rapt Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Chlorambucil
  • Sponsor:F. Hoffmann-La Roche AG
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB

Breast cancer

Not recruiting

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Pfizer Inc.

Neoplasm malignant

Not recruiting

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer Consumer Care AG

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Vratsa

What the registry says about research in the country

01 Respiratory Medicine

Extensive research focusing on asthma and COPD treatments, evaluating novel therapies and combinations to improve lung function and reduce exacerbations.

  • Asthma control optimization
  • COPD management strategies
  • Respiratory function assessment

Multiple trials testing innovative inhaler formulations and biological treatments for better disease control.

02 Oncology Research

Groundbreaking studies in breast cancer and leukemia, with particular focus on targeted therapies and combination treatments.

  • Metastatic breast cancer treatments
  • Chronic lymphocytic leukemia therapies
  • Cancer cachexia management

Innovative approaches combining established treatments with novel therapeutic agents.

03 Mental Health Studies

Comprehensive research in psychiatric disorders, including trials for schizophrenia, anxiety, and depression treatments.

  • Schizophrenia management
  • Generalized Anxiety Disorder
  • Major Depressive Disorder

Focus on developing effective adjunctive therapies and new treatment options for resistant cases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.